{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:26:19Z","timestamp":1773415579916,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and importance:<\/jats:title>\n                    <jats:p>Ovarian carcinosarcomas (OCS) are highly aggressive tumors containing both carcinomatous and sarcomatous elements. Patients are typically older postmenopausal women who present with advanced disease, however rarely young women can be affected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>A 41-year-old woman undergoing fertility treatment was found to have a new 9-10 cm pelvic mass on routine transvaginal ultrasound (TVUS) 16 days after embryo transfer. Diagnostic laparoscopy revealed a mass in the posterior cul-de-sac that was surgically excised and sent to pathology for evaluation. Pathology was consistent with carcinosarcoma of gynecologic origin. Further work-up revealed advanced disease with apparent rapid progression. Patient underwent interval debulking surgery after four cycles of neoadjuvant chemotherapy with carboplatin and paclitaxel with final pathology consistent with primary ovarian carcinosarcoma and complete gross resection of disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion:<\/jats:title>\n                    <jats:p>In the setting of advanced disease neoadjuvant chemotherapy with a platinum-based chemotherapy regimen followed by cytoreductive surgery is a standard approach to treatment of OCS. Given the rarity of disease, most data regarding treatment has been extrapolated from other forms of epithelial ovarian cancer. Specific risk factors for disease development of OCS including the long-term effects of assisted reproductive technology remain understudied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>While OCS are rare highly aggressive biphasic tumors that primarily affect older postmenopausal woman, we present a unique case of OCS incidentally found in a young woman undergoing fertility treatment via in-vitro fertilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2023.107937","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T11:52:25Z","timestamp":1676634745000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Metastatic ovarian carcinosarcoma in a patient undergoing in-vitro fertilization"],"prefix":"10.1097","volume":"104","author":[{"given":"Matthew","family":"Flint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Velasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Kolev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Zakashansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20260313","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2011.12.418","article-title":"Carcinosarcoma of the ovary: a review of the literature","volume":"125","author":"del Carmen","year":"2012","journal-title":"Gynecol. Oncol"},{"key":"R2-20-20260313","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2013.06.034","article-title":"Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome","volume":"131","author":"George","year":"2013","journal-title":"Gynecol. Oncol"},{"key":"R4-20-20260313","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2016.06.003","article-title":"Carcinosarcoma of the ovary, fallopian tube, and peritoneum: prognostic factors and treatment modalities","volume":"142","author":"Rauh-Hain","year":"2016","journal-title":"Gynecol. Oncol"},{"key":"R5-20-20260313","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.critrevonc.2018.12.006","article-title":"Ovarian carcinosarcoma: current developments and future perspectives","volume":"134","author":"Boussios","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"R6-20-20260313","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg"},{"key":"R7-20-20260313","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10147-017-1153-7","article-title":"Biphasic malignant tumours of the abdominal cavity","volume":"22","author":"Almond","year":"2017","journal-title":"Int. J. Clin. Oncol"},{"key":"R8-20-20260313","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/COC.0b013e3182979b27","article-title":"Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy","volume":"38","author":"Pacaut","year":"2015","journal-title":"Am. J. Clin. Oncol"},{"key":"R10-20-20260313","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10147-017-1215-x","article-title":"Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment","volume":"23","author":"Yalcin","year":"2018","journal-title":"Int. J. Clin. Oncol"},{"key":"R11-20-20260313","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/IGC.0000000000000228","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma","volume":"24","author":"Berton-Rigaud","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"R12-20-20260313","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ygyno.2007.01.037","article-title":"Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering cancer center experience","volume":"105","author":"Leiser","year":"2007","journal-title":"Gynecol. Oncol"},{"key":"R13-20-20260313","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PAP.0b013e318253465d","article-title":"Value of PAX 8 immunostaining in tumor diagnosis: a review and update","volume":"19","author":"Ordonez","year":"2012","journal-title":"Adv. Anat. Pathol"},{"key":"R14-20-20260313","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2004.01.018","article-title":"Retroperitoneal mullerian carcinosarcoma associated with endometriosis: a case report","volume":"93","author":"Booth","year":"2004","journal-title":"Gynecol. Oncol"},{"key":"R15-20-20260313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-019-05358-8","article-title":"Endometriosis and risk of ovarian cancer: what do we know?","volume":"301","author":"Kralickova","year":"2020","journal-title":"Arch. Gynecol. Obstet"},{"key":"R16-20-20260313","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/djaa163","article-title":"Long-term risk of ovarian cancer and borderline tumors after assisted reproductive technology","volume":"113","author":"Spaan","year":"2021","journal-title":"J. Natl. Cancer Inst"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2023.107937","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:01:09Z","timestamp":1773403269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2023.107937"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":14,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2023.107937","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}